Cargando…

Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis

BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Nadja Pinto, Júnior, Alexander Leonardo S., Soares, Geyse Adriana S., Costa, Thainá Cristina C., dos Santos, Alicia Patrine C., Costa, Allyson Guimarães, Tarragô, Andréa Monteiro, Martins, Rejane Nina, do Carmo Leão Pontes, Flávia, de Almeida, Emerson Garcia, de Paula, Erich Vinícius, Martins-Filho, Olindo Assis, Malheiro, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199620/
https://www.ncbi.nlm.nih.gov/pubmed/32411797
http://dx.doi.org/10.1155/2020/4585704
_version_ 1783529182845730816
author Garcia, Nadja Pinto
Júnior, Alexander Leonardo S.
Soares, Geyse Adriana S.
Costa, Thainá Cristina C.
dos Santos, Alicia Patrine C.
Costa, Allyson Guimarães
Tarragô, Andréa Monteiro
Martins, Rejane Nina
do Carmo Leão Pontes, Flávia
de Almeida, Emerson Garcia
de Paula, Erich Vinícius
Martins-Filho, Olindo Assis
Malheiro, Adriana
author_facet Garcia, Nadja Pinto
Júnior, Alexander Leonardo S.
Soares, Geyse Adriana S.
Costa, Thainá Cristina C.
dos Santos, Alicia Patrine C.
Costa, Allyson Guimarães
Tarragô, Andréa Monteiro
Martins, Rejane Nina
do Carmo Leão Pontes, Flávia
de Almeida, Emerson Garcia
de Paula, Erich Vinícius
Martins-Filho, Olindo Assis
Malheiro, Adriana
author_sort Garcia, Nadja Pinto
collection PubMed
description BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflammatory cytokines. The immune system has a close connection with morbidity in SCA, but further studies are needed to uncover the involvement of innate and adaptive immunities in modulating the SCA physiopathology. We performed measurements of the frequency of innate and adaptive immunity cells, cytokines, chemokines, and growth factors and immunophenotyping of Toll-like receptor and adhesion molecule expression in the blood of SCA patients and healthy donors to evaluate the different profiles of these biomarkers, the relationship among them, and their correlation to laboratory records and death risk. Material and Methods. Immunophenotyping of cells, Toll-like receptors, and adhesion molecules were performed from peripheral blood samples of SCA patients and healthy donors by flow cytometry and cytokine/chemokine/growth factor measurement by the Luminex technique performed from the serum of the same subjects. RESULTS: Cells of adaptive immunity such as IL-12, IL-17, and IL-10 cytokines; IL-8, IP-10, MIP-1α, MIP-1β, and RANTES chemokines; and VEGF, FGF-basic, and GM-CSF growth factors were higher in SCA patients than healthy donors regardless of any laboratorial and clinical condition. However, high death risk appears to have relevant biomarkers. CONCLUSION: In the SCA pathophysiology at steady state, there is a broad immunological biomarker crosstalk highlighted by TCD4+CD69+ lymphocytes, IL-12 and IL-17 inflammatory and IL-10 regulatory cytokines, MIP-1α, MIP-1β, and IP-10 chemokines, and VEGF growth factor. High expression of TLR2 in monocytes and VLA-4 in TCD8+ lymphocytes and high levels of MIP-1β and RANTES appear to be relevant in high death risk conditions. The high reticulocytosis and high death risk conditions present common correlations, and there seems to be a balance by the Th2 profile.
format Online
Article
Text
id pubmed-7199620
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71996202020-05-14 Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis Garcia, Nadja Pinto Júnior, Alexander Leonardo S. Soares, Geyse Adriana S. Costa, Thainá Cristina C. dos Santos, Alicia Patrine C. Costa, Allyson Guimarães Tarragô, Andréa Monteiro Martins, Rejane Nina do Carmo Leão Pontes, Flávia de Almeida, Emerson Garcia de Paula, Erich Vinícius Martins-Filho, Olindo Assis Malheiro, Adriana J Immunol Res Research Article BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflammatory cytokines. The immune system has a close connection with morbidity in SCA, but further studies are needed to uncover the involvement of innate and adaptive immunities in modulating the SCA physiopathology. We performed measurements of the frequency of innate and adaptive immunity cells, cytokines, chemokines, and growth factors and immunophenotyping of Toll-like receptor and adhesion molecule expression in the blood of SCA patients and healthy donors to evaluate the different profiles of these biomarkers, the relationship among them, and their correlation to laboratory records and death risk. Material and Methods. Immunophenotyping of cells, Toll-like receptors, and adhesion molecules were performed from peripheral blood samples of SCA patients and healthy donors by flow cytometry and cytokine/chemokine/growth factor measurement by the Luminex technique performed from the serum of the same subjects. RESULTS: Cells of adaptive immunity such as IL-12, IL-17, and IL-10 cytokines; IL-8, IP-10, MIP-1α, MIP-1β, and RANTES chemokines; and VEGF, FGF-basic, and GM-CSF growth factors were higher in SCA patients than healthy donors regardless of any laboratorial and clinical condition. However, high death risk appears to have relevant biomarkers. CONCLUSION: In the SCA pathophysiology at steady state, there is a broad immunological biomarker crosstalk highlighted by TCD4+CD69+ lymphocytes, IL-12 and IL-17 inflammatory and IL-10 regulatory cytokines, MIP-1α, MIP-1β, and IP-10 chemokines, and VEGF growth factor. High expression of TLR2 in monocytes and VLA-4 in TCD8+ lymphocytes and high levels of MIP-1β and RANTES appear to be relevant in high death risk conditions. The high reticulocytosis and high death risk conditions present common correlations, and there seems to be a balance by the Th2 profile. Hindawi 2020-01-08 /pmc/articles/PMC7199620/ /pubmed/32411797 http://dx.doi.org/10.1155/2020/4585704 Text en Copyright © 2020 Nadja Pinto Garcia et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Garcia, Nadja Pinto
Júnior, Alexander Leonardo S.
Soares, Geyse Adriana S.
Costa, Thainá Cristina C.
dos Santos, Alicia Patrine C.
Costa, Allyson Guimarães
Tarragô, Andréa Monteiro
Martins, Rejane Nina
do Carmo Leão Pontes, Flávia
de Almeida, Emerson Garcia
de Paula, Erich Vinícius
Martins-Filho, Olindo Assis
Malheiro, Adriana
Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title_full Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title_fullStr Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title_full_unstemmed Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title_short Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
title_sort sickle cell anemia patients display an intricate cellular and serum biomarker network highlighted by tcd4+cd69+ lymphocytes, il-17/mip-1β, il-12/vegf, and il-10/ip-10 axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199620/
https://www.ncbi.nlm.nih.gov/pubmed/32411797
http://dx.doi.org/10.1155/2020/4585704
work_keys_str_mv AT garcianadjapinto sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT junioralexanderleonardos sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT soaresgeyseadrianas sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT costathainacristinac sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT dossantosaliciapatrinec sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT costaallysonguimaraes sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT tarragoandreamonteiro sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT martinsrejanenina sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT docarmoleaopontesflavia sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT dealmeidaemersongarcia sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT depaulaerichvinicius sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT martinsfilhoolindoassis sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis
AT malheiroadriana sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis